Effects of a non-IGF binding mutant of IGFBP-5 on cell death in human breast cancer cells.

We have demonstrated previously that IGFBP-5 alone had no effect on cell death but modulated ceramide-induced apoptosis in Hs578T IGF non-responsive cells. To investigate if IGFBP-5 maintains its intrinsic ability to modulate apoptosis in IGF-responsive cells, we used a non-IGF binding mutant of IGFBP-5. In Hs578T cells, non-glycosylated, glycosylated or mutant IGFBP-5 alone each had no effect on cell death, whereas all forms inhibited ceramide-induced apoptosis. In IGF-responsive MCF-7 cells, each wild type form reduced ceramide-induced cell death but mutant IGFBP-5 was without effect. In the presence of mutant IGFBP-5, however, IGF-I no longer conferred survival and in the presence of wild type IGFBP-5, long R3 IGF-I was also unable to confer survival. In summary, all forms of IGFBP-5 modulated ceramide-induced apoptosis in Hs578T cells. In MCF-7 cells, IGF-I-induced survival could be facilitated by IGFBP-5, but also blocked by IGFBP-5 if association with IGFBP-5 was prevented.

[1]  J. Irving,et al.  Functional role of cell surface integrins on human trophoblast cell migration: regulation by TGF-beta, IGF-II, and IGFBP-1. , 1995, Experimental cell research.

[2]  R. Voutilainen,et al.  Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. , 1988, Endocrinology.

[3]  D. Flint,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Hormonal Control of Insulin-Like Growth Factor- Binding Protein-5 Production in the Involuting Mammary Gland of the Rat* , 2022 .

[4]  C. Abrass,et al.  Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration. , 1997, American journal of physiology. Renal physiology.

[5]  T. Nam,et al.  Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. , 2000, Endocrinology.

[6]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[7]  D. Clemmons,et al.  Blocking ligand occupancy of the αVβ3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells , 1998 .

[8]  P. Cohen,et al.  Insulin‐like growth factor binding protein 5 is associated with involution of the ventral prostate in castrated and finasteride‐treated rats , 1998, The Prostate.

[9]  D. Clemmons.  Role of insulin-like growth factor binding proteins in controlling IGF actions , 1998, Molecular and Cellular Endocrinology.

[10]  D. Andress.  Insulin-like growth factor-binding protein-5 (IGFBP-5) stimulates phosphorylation of the IGFBP-5 receptor. , 1998, American Journal of Physiology. Endocrinology and Metabolism.

[11]  R. Baxter,et al.  Insulin-like Growth Factor-binding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[12]  R. Rosenfeld,et al.  Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. , 1993, The Journal of biological chemistry.

[13]  L. Maile,et al.  The role of cell surface attachment and proteolysis in the insulin-like growth factor (IGF)-independent effects of IGF-binding protein-3 on apoptosis in breast epithelial cells. , 1999, Endocrinology.

[14]  P. Newcomb,et al.  Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines , 1999, British Journal of Cancer.

[15]  C. Thompson,et al.  Apoptosis in the pathogenesis and treatment of disease , 1995, Science.

[16]  L. Maile,et al.  Structural analysis of the role of the beta 3 subunit of the alpha V beta 3 integrin in IGF-I signaling. , 2001, Journal of cell science.

[17]  M. Rechler.  Insulin-like growth factor binding proteins. , 1993, Vitamins and hormones.

[18]  L. Maile,et al.  Structural analysis of the role β3 subunit of the αVβ3 integrin in IGF-I signaling , 2001 .

[19]  C. Abrass,et al.  IGFBP-5(201-218) stimulates Cdc42GAP aggregation and filopodia formationin migrating mesangial cells. , 2000, Kidney international.

[20]  D. Clemmons,et al.  Substitutions for Hydrophobic Amino Acids in the N-terminal Domains of IGFBP-3 and -5 Markedly Reduce IGF-I Binding and Alter Their Biologic Actions* , 2000, The Journal of Biological Chemistry.

[21]  D. Flint,et al.  Insulin-Like Growth Factor Binding Proteins: IGF-Dependent and -Independent Effects in the Mammary Gland , 2004, Journal of Mammary Gland Biology and Neoplasia.

[22]  M. Ranke,et al.  Insulin-like growth factor I (IGF-I)-binding protein complex is a better mitogen than free IGF-I. , 1989, Endocrinology.

[23]  D. Clemmons,et al.  Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  A. Wyllie,et al.  Cell death: the significance of apoptosis. , 1980, International review of cytology.

[25]  S. Bowen,et al.  Differential IGF‐independent effects of insulin‐like growth factor binding proteins (1–6) on apoptosis of breast epithelial cells , 1999, Journal of cellular biochemistry.

[26]  P. Newcomb,et al.  Effect of insulin-like growth factor binding protein-1 on integrin signalling and the induction of apoptosis in human breast cancer cells. , 1999, Journal of molecular endocrinology.

[27]  S. Mohan,et al.  Evidence that IGF-binding protein-5 functions as a growth factor. , 2001, The Journal of clinical investigation.